Real-world utilization pattern of pexidartinib in patients with tenosynovial giant cell tumor (TGCT)

被引：0
|
作者：
Lin, Feng
Tse, Jenny
Shaikh, Nazneen Fatima
Wang, Elizabeth J.
Near, Aimee
Kwong, Jackie
Tap, William D.
机构：
[1] Daiichi Sankyo Inc, Basking Ridge, NJ USA
[2] IQVIA, Durham, NC USA
[3] Mem Sloan Kettering Canc Ctr, Sarcoma Med Oncol Serv, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18792
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ENLIVEN study: Pexidartinib for tenosynovial giant cell tumor (TGCT)
    Tap, William
    FUTURE ONCOLOGY, 2020, 16 (25) : 1875 - 1878
  • [2] REAL-WORLD EXPERIENCE OF PATIENTS NEWLY INITIATED ON PEXIDARTINIB FOR TENOSYNOVIAL GIANT CELL TUMOR
    Dai, D.
    Tecson, K.
    Pan, I
    Ye, X.
    Tap, W. D.
    VALUE IN HEALTH, 2024, 27 (06) : S390 - S391
  • [3] Real-World Patient Experience of Pexidartinib for Tenosynovial Giant-Cell Tumor
    Lin, Feng
    Kwong, Winghan Jacqueline
    Pan, Irene
    Ye, Xin
    Dai, Dong
    Tap, William
    ONCOLOGIST, 2024, 29 (04): : e535 - e543
  • [4] Patient-reported continued benefits of pexidartinib for tenosynovial giant cell tumor based on a real-world study in the United States
    Dai, Dong
    Pan, Irene
    Freivogel, Klaus
    Ye, Xin
    Tecson, Kristen
    Tap, William
    ONCOLOGIST, 2025, 30 (03):
  • [5] FDA Approves Pexidartinib in Tenosynovial Giant Cell Tumor
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (09) : 498 - 498
  • [6] Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA
    Dharmani, Charles
    Fofah, Oluwatosin
    Wang, Eric
    Salas, Maribel
    Wooddell, Margaret
    Tu, Nora
    Tse, Jenny
    Near, Aimee
    Tinoco, Gabriel
    FUTURE ONCOLOGY, 2024, 20 (16) : 1079 - 1097
  • [7] Pexidartinib: first approved systemic therapy for patients with tenosynovial giant cell tumor
    Gelderblom, Hans
    van de Sande, Michiel
    FUTURE ONCOLOGY, 2020, 16 (29) : 2345 - 2356
  • [8] Pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor: safety and efficacy
    Palmerini, Emanuela
    Longhi, Alessandra
    Donati, Davide Maria
    Staals, Eric Lodewijk
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (06) : 441 - 445
  • [9] Safety and preliminary efficacy of vimseltinib in tenosynovial giant cell tumor (TGCT)
    Gelderblom, H.
    Razak, A. R. Abdul
    Sanchez-Gastaldo, A.
    Rutkowski, P.
    Wilky, B.
    Wagner, A.
    van de Sande, M.
    Michenzie, M.
    Vallee, M.
    Sharma, M.
    Sherman, M. L.
    Ruiz-Soto, R.
    Tap, W.
    ANNALS OF ONCOLOGY, 2021, 32 : S1233 - S1234
  • [10] Prospects of Treating Tenosynovial Giant Cell Tumor through Pexidartinib: A Review
    Alsayadi, Yunes M. M. A.
    Chawla, Pooja A.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (12) : 1510 - 1519
12345